Standard testing can miss some tumors, which are later diagnosed and called interval cancers. They’re often more aggressive ...
Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital health and wellness platform, launched access to the Hims & ...
Engineered yeast cells can mimic real cancer cells and be used to test new cancer immunotherapies much faster, benefiting patients.
Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech continues to gather up trial data for a potential FDA approval next year. | Telehealth ...
spot on news US on MSN
World Cancer Day on February 4th: These screening examinations count
World Cancer Day on February 4th urges early detection. From Pap smears at 20 to colonoscopies at 50: The statutory program ...
Hims & Hers Health shares are trending Wednesday after the company announced it launched access to the Hims & Hers Multi-Cancer Test.
Blood and saliva tests to detect cancer before symptoms begin ‘could be part of NHS screening within a decade’ - The ...
MedPage Today on MSN
Single Midlife PSA Test May Identity Long-Term Prostate Cancer Risk
Many men with low levels could be spared from invasive procedures and frequent testing ...
England’s National Health Service’s faecal immunochemical test (FIT) has reduced referrals for suspected bowel cancer by ...
News-Medical.Net on MSN
Self-collected HPV tests match clinical screening
By Vijay Kumar Malesu New national data from Australia show that opening self-collected HPV testing to everyone dramatically increases uptake among those least likely to be screened, and preserves the ...
A recent study reveals significant progress in biomarker testing for lung cancer in community settings, highlighting the need ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results